International Journal of Molecular Biotechnological Research

Editors Overview

ijmbr maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Open Access
Special Issue
Topic

Gene Therapy Promises and its Treatment promises

Abstract Submission Deadline : November 30, 2023

Manuscript Submission Deadline : December 25, 2023

Special Issue Description

Gene therapy attempts to treat illness or strengthen your body’s resistance to illness by replacing a damaged gene or adding a new gene. Numerous disorders, including cancer, cystic fibrosis, heart disease, diabetes, hemophilia, and AIDS, may be treated with gene therapy. One of the biggest technical difficulties in contemporary medicine is gene therapy. Maintaining the function of newly introduced genes in bodily cells is highly challenging. Additionally, there are financial issues: To treat illness or strengthen your body’s resistance to illness, gene therapy replaces a defective gene or introduces a new gene. Gene therapy has promise in the treatment of a variety of illnesses, including AIDS, cancer, cystic fibrosis, heart disease, diabetes, and hemophilia.

Keywords

Gene , Illness , AIDS , Cancer , Hemophilia

Manuscript Submission information

Manuscripts should be submitted online via the manuscript Engine. Once you register on APID, click here to go to the submission form. Manuscripts can be submitted until the deadline.
All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the email address:[email protected] for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a Double-blind peer-review process. A guide for authors and other relevant information for the submission of manuscripts is available on the Instructions for Authors page.

Participating journals: